Navigation Links
SiREM and Tersus Environmental Form Strategic Marketing Alliance
Date:2/23/2012

GUELPH, Ontario and WAKE FOREST, N.C., Feb. 23, 2012 /PRNewswire/ -- SiREM (www.siremlab.com) and Tersus Environmental (www.tersusenv.com) announced today the signing of a Sales Agency Agreement between the two firms. Under the terms of the agreement, Tersus Environmental will market, promote and sell SiREM's bioaugmentation cultures – KB-1® and KB-1® Plus – as well as Gene-Trac® molecular testing services and treatability studies.

SiREM provides tools environmental professionals need to optimize remediation of chlorinated solvents and other recalcitrant chemicals, helping clients save money, increase remediation effectiveness and provide peace of mind during field implementation.

Tersus Environmental is a developer and marketer of advanced, innovative technologies for the remediation of soil and groundwater and is the exclusive marketing channel for inVentures Technologies groundwater products – including iSOC® Gas inFusion technology and the gPRO® oxygenation systems – as well as their various remedial uses.

"We have always been impressed with SiREM's leadership in the area of bioremediation and treatability studies," says Gary Birk, Managing Partner, Tersus. "As an industry leader, SiREM distinguishes itself from other solutions providers with a unique range of products and testing services combined with unparalleled technical support."

"We are keen to work with Tersus," says Peter Dollar, Managing Director of SiREM. "Tersus' network of sales associates and staff around the world will help provide a much broader support function to those customers using KB-1 and related services. Our joint resources give Tersus customers the best biotechnology-based solutions to manage complex, challenging environmental liabilities and reduce costs for site closure."

 


'/>"/>
SOURCE SiREM; Tersus Environmental
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Bion Announces Approval of New U.S. Patent for Phosphorus Removal Process for Livestock Waste Environmental Treatment
2. Environmental Tectonics Corporations Sterilization Systems Group Announces New Contracts
3. Environmental Tectonics Corporation Announces a Multiple Sale for Monoplace Hyperbaric Chambers
4. Bion Announces Approval of New Australian Patent for Low Oxygen Organic Waste Bioconversion for Livestock Waste Environmental Treatment
5. Environmental Tectonics Corporation Announces the Placement of Two Monoplace Hyperbaric Chambers at Saint Barnabas Medical Center in New Jersey
6. Environmental Tectonics Corporation Announces a Multiple Sale of Hyperbaric Monoplace Chambers to Comprehensive Healthcare Solutions
7. High-quality DNA/RNA from Microorganisms in Environmental Samples
8. SRNLs microbes useful for for environmental cleanup and oil recovery
9. Shengtai Pharmaceutical Completes Factory Improvements Resulting in Operational and Environmental Benefits
10. Environmental Tectonics Corporations BioMedical Systems Division Places Two Monoplace Chambers at East Orange (NJ) General Hospital
11. Environmental Tectonics Corporations Simulation Division Receives New ADMS Contract from Netherlands Institute for Safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... PRINCETON, N.J. , July 24, 2014 /PRNewswire/ ... largest provider of regulatory and ethical review services ... acquired Alliance Biosciences. Formerly a division of ... Biosciences was the leading biosafety and biosecurity consulting ... . With this addition, WCG,s biosafety division – ...
(Date:7/24/2014)... 24, 2014   Cypher Genomics, Inc., ... of Adam Simpson as president and ... and comprehensive annotation and interpretation of individual human ... "Cypher,s technology has the potential to play ... diagnostic accuracy, optimizing therapeutic approaches and reducing adverse ...
(Date:7/23/2014)... July 23, 2014  Sangamo BioSciences, Inc. (NASDAQ: ... financial results and accomplishments. For the ... consolidated net loss of $7.0 million, or $0.10 per ... or $0.10 per share, for the same period in ... cash, cash equivalents, marketable securities and interest receivable of ...
(Date:7/23/2014)... July 23, 2014  AuraSense Therapeutics, the pioneer ... gene regulatory and immunotherapeutic agents, announced today ... AuraSense Therapeutics, executive leadership team as chief ... Prior to joining AuraSense Therapeutics, Mr. Snyder ... Officer of Cellular Dynamics International Inc., where ...
Breaking Biology Technology:WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 3Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology 2Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology 3Sangamo BioSciences Reports Second Quarter 2014 Financial Results 2Sangamo BioSciences Reports Second Quarter 2014 Financial Results 3Sangamo BioSciences Reports Second Quarter 2014 Financial Results 4Sangamo BioSciences Reports Second Quarter 2014 Financial Results 5Sangamo BioSciences Reports Second Quarter 2014 Financial Results 6Sangamo BioSciences Reports Second Quarter 2014 Financial Results 7Sangamo BioSciences Reports Second Quarter 2014 Financial Results 8Sangamo BioSciences Reports Second Quarter 2014 Financial Results 9AuraSense Therapeutics Appoints Biotechnology Veteran David S. Snyder as Chief Financial Officer 2
... Enrollment in First Cohort --, SAN DIEGO, ... today announced that the Company,has completed enrollment of ... trial,to assess the safety and tolerability of new ... The trial is expected to dose up to ...
... (OTC Bulletin Board: NILT.OB), a biopharmaceutical company focused ... Mr.,Pedro Granadillo was appointed on October 16, 2007 ... is a highly-respected pharmaceutical industry,leader with over 30 ... and quality assurance. "We are pleased to ...
... AMICAS, Inc. (Nasdaq: AMCS ),a leader in radiology ... will present to and meet with investors at,the CIBC ... New,York. (Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO ), WHEN: ... begins promptly at 10:20 a.m. (Eastern Time), 9:20 a.m. ...
Cached Biology Technology:Nventa updates progress of cervical dysplasia trial with new HspE7 2Nventa updates progress of cervical dysplasia trial with new HspE7 3Nventa updates progress of cervical dysplasia trial with new HspE7 4Nventa updates progress of cervical dysplasia trial with new HspE7 5Nile Therapeutics Appoints Pedro Granadillo to Board of Directors 2Nile Therapeutics Appoints Pedro Granadillo to Board of Directors 3
(Date:7/24/2014)... have decreased by 45% on average over a 35 ... a study on the impact of humans on declining ... benefits invertebrates such as insects, spiders, crustaceans, slugs and ... pest control for crops, decomposition for nutrient cycling, water ... Science and led by UCL, Stanford and ...
(Date:7/24/2014)... product of 3.5 billion years of evolutionary trial and ... But it may be reaching a tipping point. , ... of data published in Science , an international ... of animals is contributing to what appears to be ... extinction event. , Since 1500, more than 320 terrestrial ...
(Date:7/24/2014)... July 24, 2014(BRONX, NY)Researchers at Albert Einstein College ... grant from The Michael J. Fox Foundation for Parkinson,s ... treatment for Parkinson,s disease. This drug discovery project will ... the goal of developing a drug that acts on ... current therapies for Parkinson,s help many people manage their ...
Breaking Biology News(10 mins):Invertebrate numbers nearly halve as human population doubles 2Invertebrate numbers nearly halve as human population doubles 3Stanford biologist warns of early stages of Earth's 6th mass extinction event 2Stanford biologist warns of early stages of Earth's 6th mass extinction event 3Albert Einstein College of Medicine receives grant from the Michael J. Fox Foundation to fund drug discovery project targeting Parkinson's 2Albert Einstein College of Medicine receives grant from the Michael J. Fox Foundation to fund drug discovery project targeting Parkinson's 3
... New Orleans, LA Dr. John England, Professor and ... analyzed research findings and was responsible for the quality and ... resulting in new guidelines for treating Lou Gehrig,s disease, or ... the October 13, 2009 issue of Neurology , the ...
... knowledge and technology from the developed to the developing ... Africa. Professor Howard Atkinson (University of Leeds) will report ... at a landmark meeting at Rothamsted Research on Tuesday ... delegates. The project aims to enable African scientists to ...
... strikingly banded rocks scattered across the upper Midwest and ... past, offering clues to the environment of the early ... banded iron formations or BIFs, these ancient rocks formed ... was then the bottom of the ocean. The stripes ...
Cached Biology News:LSUHSC's England plays key role in developing new ALS treatment guidelines 2Banded rocks reveal early Earth conditions, changes 2Banded rocks reveal early Earth conditions, changes 3
... Intended Use: Vision Mount is formulated for covering tissue ... soluble OR alcohol insoluble end products. , ... ... chromogens such as Fast-Red or AEC that require an aqueous ...
... potent Rnase free Ribonuclease Inhibitor ... broad range of temperatures and ... not inhibit SP6, T7, or ... M-MLV reverse transcriptase or Taq ...
... kit, 110 to 220 V, enables ... doubles flow rates and valve capacity ... kit includes the Maximizer base unit, ... tubing kit, system cable 30, and ...
Mouse monoclonal antibody to QDPR - quinoid dihydropteridine reductase...
Biology Products: